Back

Real-word elegibiliy and tolerability of vericiguat in HFrEF: data from a multicenter registry

11 May 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Challenges and solutions in guideline-directed therapy in heart failure Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Savina Nodari

University of Brescia, Brescia (Italy)

4 More presentations in this session

Presentation thumbnail
Effect of GDMT optimization on KDIGO risk categories in HFrEF
Doctor N. Panagiotides (Vienna, AT)
Abstract Slides
Presentation thumbnail
Treatment patterns of heart failure patients with reduced or mildly reduced ejection fraction on dapagliflozin: baseline data from the 3rd interim analysis of two EVOLUTION-HF DEallEF study cohorts
Professor M. Paul (Muenster, DE)
Abstract Slides
Presentation thumbnail
Comparison of the 2016 and 2025 ASE/EACVI Guidelines on HFpEF
Miss W. Hu (Hangzhou, CN)
Abstract Slides
Presentation thumbnail
Bridging inequity in HFpEF care: pilot project experience informing the design and implementation of a multidisciplinary blueprint
Doctor M. Lee (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Challenges and solutions in guideline-directed therapy in heart failure

The Event

Event poster

Heart Failure 2026

11 May 2026 12:30 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources